Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update.
The treatment of moderate or severe hypertension in most cases requires the contemporaneous use of multiple antihypertensive agents. The most available two-drug combinations have an agent that addresses renin secretion and another one that is statistically more effective in renin-independent hypertension. The practice of combining agents that counteract different mechanisms is the most likely explanation for the fact that most available two-drug combinations have an agent that addresses renin secretion (beta-blocker, angiotensin converting enzyme inhibitor, angiotensin II receptor blocker or direct renin inhibitor) and another one that is more effective in renin-independent hypertension (diuretic, dihydropyridine or non-dihydropyridine calcium channel blocker). Based on these considerations, addition of hydrochlorothiazide to the combination of an antagonist of the renin-angiotensin system with a calcium channel blocker would constitute a logical approach. Inclusion of a diuretic in the triple combination is based on the evidence that these agents are effective and cheap, enhance the effect of other antihypertensive agents, and add a specific effect to individuals with salt-sensitivity of blood pressure. The benefit of triple combination therapy with amlodipine, valsartan and hydrochlorothiazide over its dual component therapies has been demonstrated, and the use of a single pill will simplify therapy resulting in better blood pressure control.
Destro
Maurizio
M
Internal Medicine, Ospedale Unificato Broni-Stradella, Stradella (PV), Italy. maurizio_destro@ospedali.pavia.it
Cagnoni
Francesca
F
D'Ospina
Antonio
A
Ricci
Alessandra Rossi
AR
Demichele
Elena
E
Peros
Emmanouil
E
Zaninelli
Augusto
A
Preti
Paola
P
D017311:Amlodipine / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination / Q000379:methods; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D013777:Tetrazoles / Q000627:therapeutic use*; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000068756:Valsartan
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D013777:Tetrazoles; D006852:Hydrochlorothiazide; D017311:Amlodipine; D000068756:Valsartan; D014633:Valine
Ann Intern Med. 2001 Nov 6;135(9):825-34
11694107
Eur J Cardiovasc Prev Rehabil. 2006 Feb;13(1):13-29
16449860
Hypertension. 2004 Jan;43(1):10-7
14638619
Circulation. 2003 Feb 4;107(4):574-8
12566369
Lancet. 2005 Jan 15-21;365(9455):217-23
15652604
Hypertension. 2008 Mar;51(3):767-72
18227405
Lancet. 2005 Sep 10-16;366(9489):895-906
16154016
Hypertension. 2003 Dec;42(6):1206-52
14656957
Curr Hypertens Rep. 2002 Oct;4(5):343-9
12217251
Hypertension. 2003 Mar;41(3):431-6
12623939
Am J Physiol. 1994 Aug;267(2 Pt 2):R579-89
8067471
J Clin Hypertens (Greenwich). 2007 May;9(5):355-64
17485971
J Hypertens. 2007 Sep;25(9):1751-62
17762635
Am J Cardiovasc Drugs. 2009;9(6):411-8
19929039
Hypertension. 2008 Apr;51(4):841-7
18332285
Int J Clin Pract. 2009 Feb;63(2):217-25
19196360
Am Heart J. 2008 Aug;156(2):241-7
18657652
Curr Med Res Opin. 2007 Feb;23(2):259-70
17288679
Vasc Health Risk Manag. 2010 Sep 07;6:821-7
20859551
Medicine (Baltimore). 2006 Mar;85(2):86-94
16609347
Clin Ther. 2007 Feb;29(2):279-89
17472820
Hypertension. 2009 Jul;54(1):32-9
19470877
J Clin Hypertens (Greenwich). 2008 Jan;10(1 Suppl 1):20-6
18174780
J Manag Care Pharm. 2006 Apr;12(3):239-45
16623608
J Hypertens. 2009 Nov;27(11):2121-58
19838131
Am J Health Syst Pharm. 2007 Jun;64(12):1279-83
17563050
Lancet. 2007 Apr 28;369(9571):1431-1439
17467513
JAMA. 2003 Dec 3;290(21):2805-16
14657064
J Am Soc Hypertens. 2008 Jul-Aug;2(4):294-302
20409909
J Clin Hypertens (Greenwich). 2002 Nov-Dec;4(6):393-404
12461301
BMJ. 1998 Sep 12;317(7160):703-13
9732337
Lancet. 2003 Nov 8;362(9395):1527-35
14615107
N Engl J Med. 2008 Dec 4;359(23):2417-28
19052124